Kamel Lahouel

Assistant Professor

Translational Genomics Research Institute
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (30)

Supplemental Figure 6. Correlation between the cfDNA derived from colon epithelial cells, lung cells, and pancreatic cells, and the fraction of cfDNA derived from neoplastic colon epithelial cells, lung cells, or pancreatic cells.

Year:

2025

Supplemental Figure 5. Methylation profiles using quadratic programming vs. non-negative least- squares regression using the reference matrix described in Moss et al. (43). Pearson’s correlation coefficient and p values are presented at the bottom of this figure, showing the derived contributions from each of the 25 tissue types that could be assessed.

Year:

2025

Supplementary Table 1. Demographic, clinical, and plasma cfDNA data for the patients included in the study deconvoluted by Sun et al. (3) and Moss et al. (43) by QP and NNLS. NA, not available. Supplementary Table 2. Demographic, clinical, and plasma cfDNA data for the patients included in the study deconvoluted by Loyfer et al. (44) NA, not available.

Year:

2025

Supplementary Notes 1-5. Supplementary Note 1: Origins of cell-free DNA. Supplementary Note 2: Leukocyte Lysis. Supplementary Note 3: Reference datasets and deconvolution algorithms used to interpret whole genome bisulfite sequencing data. Supplementary Note 4: Turnover rates. Supplementary Note 5: Relationships between ctDNA and tissue specific cfDNA in cancer patients.

Year:

2025

Supplemental Figure 2. The concentration of plasma cfDNA in previous described patients with cancer according to stage. (A) The concentration of cfDNA in patients of all cancer types (9). The concentration of cfDNA in patients with Stage III cancers was significantly higher than that of patients with Stage I cancers (p

Year:

2025

Supplemental Figure 10. In silico mixing experiments (N = 10) of buffy coat bisulfite sequencing data with liver (A), lung (B), colon epithelial cell (C), and left atrium (D) bisulfite sequencing data deconvoluted using the Moss et al. (43) reference matrix and quadratic programming shows excellent agreement between predicted and actual fractional contribution.

Year:

2025

Supplemental Figure 4. Methylation profiles using quadratic programming vs. non-negative least- squares regression using the reference matrix described in Sun et al. (3). Pearson’s correlation coefficient and p values are presented at the bottom of this figure, showing the derived contributions from each of the 12 tissue types that could be assessed.

Year:

2025

Subject and purpose of work This study aims to measure the impact of fuel subsidy on economic growth in 2010-2020. Materials and methods The panel model was used in the study to calculate the variables of fuel subsidies as a percentage of GDP and annual GDP growth per person for 11 energy producers and exporters. Results the study showed that fuel subsidies had a significant adverse effect on economic growth, with a 1% increase in fuel subsidies leading to a 0.19% drop in growth in the sample nations. Conclusions The findings are consistent with previous studies results and support the view that the policy of fuel subsidies hurts economic growth channels. This study attempted to measure fuel subsidies using the price GAP approach, which allows for estimating the levels of internal energy prices and specific reference prices, such as international energy prices or the price of production cost recovery.

Year:

2025

Supplementary Figure S5: Sorted SignaL scores in plasma from 20 subjects with advanced adenomas, 20 subjects with colorectal cancer, and 32 control subjects, after including 20 subjects with advanced adenoma in the training set.

Year:

2025

Supplementary Figure S5: Sorted SignaL scores in plasma from 20 subjects with advanced adenomas, 20 subjects with colorectal cancer, and 32 control subjects, after including 20 subjects with advanced adenoma in the training set.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (11)

Maria Popoli

Johns Hopkins University

UNITED STATES
View details

Christopher Douville

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Joshua Cohen

Dana-Farber Cancer Institute

UNITED STATES
View details

Kenneth Kinzler

Professor

Johns Hopkins University

UNITED STATES
View details

Chetan Bettegowda

Johns Hopkins University School of Medicine

UNITED STATES
View details

Haley Grant

Assistant Professor

University of Pittsburgh

UNITED STATES
View details

Cristian Tomasetti

Professor

Beckman Research Institute, City of Hope

UNITED STATES
View details

Yuk Ming Dennis Lo

Li Ka Shing Professor of Medicine

The Chinese University of Hong Kong (CUHK)

HONG KONG
View details

KC Allen Chan

Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG
View details

Bert Vogelstein

Johns Hopkins University School of Medicine

UNITED STATES
View details

Brenda Diergaarde

University of Pittsburgh

UNITED STATES
View details